Cardio-Renal Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Patients With Coronary Artery Disease Independent of Troponin, C-Reactive Protein, and Renal Function.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
21 04 2020
Historique:
pubmed: 18 4 2020
medline: 9 3 2021
entrez: 18 4 2020
Statut: ppublish

Résumé

Background Risk stratification among patients with coronary artery disease (CAD) is of considerable interest due to the potential to guide secondary preventive therapies. Thus, we evaluated the predictive value of soluble urokinase-type plasminogen activator receptor (suPAR) levels for cardiovascular mortality and nonfatal myocardial infarction in patients with CAD. Methods and Results Plasma levels of suPAR were measured in a cohort of 1703 patients with documented CAD as evidenced by coronary angiography-including 626 patients with acute coronary syndrome and 1077 patients with stable angina pectoris. Cardiovascular death and/or nonfatal myocardial infarction were defined as main outcome measures. During a median follow-up of 3.5 years, suPAR levels reliably predicted cardiovascular death or myocardial infarction in CAD, evidenced by survival curves stratified for tertiles of suPAR levels. In Cox regression analyses, the hazard ratio for the prediction of cardiovascular death and/or myocardial infarction was 2.19 (

Identifiants

pubmed: 32299288
doi: 10.1161/JAHA.119.015452
pmc: PMC7428542
doi:

Substances chimiques

Biomarkers 0
PLAUR protein, human 0
Receptors, Urokinase Plasminogen Activator 0
Troponin 0
C-Reactive Protein 9007-41-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e015452

Références

JAMA. 1995 Jan 11;273(2):136-41
pubmed: 7799494
Atherosclerosis. 2018 Aug;275:256-261
pubmed: 29980052
Clin Biochem. 2019 Jul;69:36-44
pubmed: 31129182
Intensive Care Med. 2012 Sep;38(9):1418-28
pubmed: 22706919
Biomolecules. 2018 Jun 15;8(2):
pubmed: 29914099
Nat Med. 2017 Jan;23(1):100-106
pubmed: 27941791
Eur Heart J. 2010 Nov;31(22):2755-64
pubmed: 20805110
N Engl J Med. 2017 Sep 21;377(12):1119-1131
pubmed: 28845751
Clin Chem. 2006 Jul;52(7):1284-93
pubmed: 16690735
Science. 2006 Feb 3;311(5761):656-9
pubmed: 16456079
Eur Heart J. 2017 Feb 14;38(7):516-523
pubmed: 27357355
Pflugers Arch. 2017 Aug;469(7-8):1017-1020
pubmed: 28689240
N Engl J Med. 2003 Oct 23;349(17):1605-13
pubmed: 14573732
J Am Heart Assoc. 2014 Oct 23;3(5):e001118
pubmed: 25341887
Biomolecules. 2018 Aug 09;8(3):
pubmed: 30096922
Am J Respir Cell Mol Biol. 2000 Mar;22(3):316-22
pubmed: 10696068
N Engl J Med. 2004 Sep 23;351(13):1296-305
pubmed: 15385656
Int J Biol Markers. 2001 Oct-Dec;16(4):233-9
pubmed: 11820717
Cell Mol Life Sci. 2000 Jan 20;57(1):25-40
pubmed: 10949579
Nat Med. 2008 Jan;14(1):55-63
pubmed: 18084301
Int J Cardiol. 2016 Oct 15;221:908-13
pubmed: 27441467
JAMA. 2010 May 12;303(18):1841-7
pubmed: 20460623
Mol Cell Biochem. 2009 Jan;321(1-2):111-22
pubmed: 18830568
N Engl J Med. 2015 Nov 12;373(20):1916-25
pubmed: 26539835
J Am Heart Assoc. 2020 Apr 21;9(8):e015452
pubmed: 32299288
Biomolecules. 2018 Jun 28;8(3):
pubmed: 29958400
Biomolecules. 2018 Jul 20;8(3):
pubmed: 30037035
N Engl J Med. 2005 Apr 21;352(16):1685-95
pubmed: 15843671
Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):1876-90
pubmed: 11742859
Biomolecules. 2018 Aug 20;8(3):
pubmed: 30127326
Nat Med. 2017 Aug;23(8):945-953
pubmed: 28650456
Ann Intern Med. 2001 Apr 17;134(8):629-36
pubmed: 11304102

Auteurs

Julius Nikorowitsch (J)

Clinic of Cardiology University Heart and Vascular Center Hamburg Hamburg Germany.

Tim Borchardt (T)

Clinic of Cardiology University Heart and Vascular Center Hamburg Hamburg Germany.

Sebastian Appelbaum (S)

Clinic of Cardiology University Heart and Vascular Center Hamburg Hamburg Germany.

Francisco Ojeda (F)

Clinic of Cardiology University Heart and Vascular Center Hamburg Hamburg Germany.

Karl J Lackner (KJ)

Department of Laboratory Medicine University Medical Center Johannes Gutenberg University Mainz Mainz Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Rhein-Main Mainz Germany.

Renate B Schnabel (RB)

Clinic of Cardiology University Heart and Vascular Center Hamburg Hamburg Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Hamburg, Lübeck, Kiel Hamburg Germany.

Stefan Blankenberg (S)

Clinic of Cardiology University Heart and Vascular Center Hamburg Hamburg Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Hamburg, Lübeck, Kiel Hamburg Germany.

Tanja Zeller (T)

Clinic of Cardiology University Heart and Vascular Center Hamburg Hamburg Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Hamburg, Lübeck, Kiel Hamburg Germany.

Mahir Karakas (M)

Clinic of Cardiology University Heart and Vascular Center Hamburg Hamburg Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Hamburg, Lübeck, Kiel Hamburg Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH